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Abstract 
 
Objective 
There is considerable interest in the concept of recovery from psychosis. Consumers 
describe recovery as a process as opposed to a clinical outcome. However, measures 
of recovery have an important role in the development of recovery based mental 
health services. This study sought to investigate the validity and reliability of the 
Stages of Recovery Instrument (STORI) [1]. This is an Australian measure chosen as 
a promising measure of recovery developed from the perspectives of consumer 
accounts. 
 
Method 
A questionnaire design was used to investigate the following aspects of validity: face 
validity and feasibility, concurrent validity, construct validity and test-retest 
reliability. Fifty people from the caseloads of three specialist mental health teams in a 
London Borough completed the STORI, the Recovery Assessment Scale [2-3] and a 
feedback questionnaire. Twenty two people completed the STORI a second time for 
the purposes of test-retest reliability exploration. 
 
Results 
Participants’ responses to the feedback questionnaire were mainly positive. This was 
seen as evidence of face validity and feasibility. Correlations between the STORI and 
the RAS provided evidence of concurrent validity. Cluster analysis revealed that the 
STORI items formed three clusters rather than five. Strong correlations between the 
first and second STORI administrations provided initial evidence for the test-retest 
reliability. 
 
Conclusions 
The STORI can be used to measure recovery concepts in the UK. However, it does 
not measure the five stage model on which it was based. A three stage model of 
recovery might best form the basis of future recovery research.  
 
Key words 
Recovery, psychosis, validity, reliability 
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Background  
Recovery is “a personal process of overcoming the negative impact of diagnosed 
mental illness / distress despite its continued presence” (NIMHE, 2004, p2). 
Supporting recovery is an emerging priority in mental health services internationally. 
A key scientific challenge is that recovery can be understood both as an outcome and 
a process.  
When considered as an outcome, the aim is to operationalise recovery in order 
to make it measurable. From this perspective, services and interventions can be 
evaluated by the extent to which people using them recover. This involves a view of 
recovery as both binary (present or absent) and invariant across people. Examples 
include an absence (or significant reduction) of symptoms (such that a diagnosis of 
psychotic illness could not be made) and an absence of psychiatric hospitalisations for 
one year (Harrow et al, 2005), two years (Liberman et al, 2002; Whitehorn et al, 
2002) and five years (Torgalsboen & Rund, 2002), as well as achieving specified 
levels of occupational and social functioning (Liberman & Kopelowicz, 2005; Harrow 
et al, 2005). 
Viewing recovery as an outcome facilitates epidemiological research, but has 
three main shortcomings. First, recovery can take a different time for different 
individuals. Therefore, determining a length of time that an individual must be, for 
example, symptom-free may not be appropriate. Second, recovery is not a static 
construct – individuals experience occasional relapses but these do not necessarily 
indicate lasting disability. Finally, invariant definitions of recovery do not allow for 
individual differences. Recovery will mean different things to different people. Some 
who fit the outcome definition of recovery may be troubled by feeling that they have 
not achieved their ambitions socially, or may feel stigmatised by their continued use 
of psychotropic medication. Others who continue to experience a level of 
symptomatology in excess of the outcome defined criteria, or who occasionally use 
psychiatric hospitals as a form of respite, may feel that they are achieving things in 
their life that gives them a positive sense of self, and manage their symptoms in such 
a way that they are able to continue doing so. These issues lead Davidson and 
colleagues (2006) to conclude that recovery “does not have as much to do with level 
of psychopathology as with how a person manages his or her life in the presence of an 
enduring illness” (p7). 
In contrast with outcome definitions, recovery has been described as a process 
individuals go through in order to live a satisfying life despite the limitations of illness 
(Anthony, 1993). When recovery is conceptualised as a unique, personal journey, it 
allows for the identification of factors that influence and support people going through 
this process (e.g. Deegan, 1996; Jacobsen & Greenley, 2001; Repper & Perkins, 2003; 
Jenkins & Carpenter-Song, 2005). Supporting these processes can then be translated 
to ‘active components’ of recovery oriented services (e.g. Care Services Improvement 
Partnership, 2007; Schrank & Slade, 2007; Shepherd, Boardman & Slade, 2008). 
Whilst conceptualising recovery as a process fits with the experience of 
service users, it does not lend itself to measurement. This is a challenge for recovery 
practice. In health services that are heavily influenced by measurement (Holloway, 
2002), services need to show that they are helping people recover. A challenge, 
therefore, is to develop an understanding of recovery that stays true to the definition 
of recovery as a process, but also lends itself to measurement. 
One such approach has been proposed by Andresen and colleagues (2003) on 
the basis of a synthesis of consumer accounts of recovery. They proposed a five stage 
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model of recovery occurring across four component processes: finding hope; re-
establishing a positive identity; finding meaning in life; and taking responsibility for 
one’s own life. Stage 1 is Moratorium - involving a time of withdrawal characterised 
by a profound sense of loss and hopelessness. Stage 2 is Awareness – a realisation 
that all is not lost, and that a fulfilling life is possible. Stage 3 is Preparation – taking 
stock of strengths and weaknesses regarding recovery, and starting to work on 
developing recovery skills. Stage 4 is Rebuilding – actively working towards a 
positive identity, setting meaningful goals and taking control of one’s life. The final 
Stage is Growth – living a full and meaningful life, characterised by self-management 
of the illness and a positive sense of self. 
 Andresen and colleagues (2003) argue that the fifth stage of recovery 
represents a measurable outcome. They therefore developed the Stage of Recovery 
Instrument (STORI) as a means of allocating individuals to their current stage of 
recovery (Andresen, Caputi & Oades, 2006). Concurrent and construct validity was 
investigated using an Australian sample of 94 members of a research database. 
Concurrent validity was demonstrated through positive correlations between scores on 
the later stages (4 and 5) and measures of hope, well-being, resilience and mental 
health, along with another measure of recovery, the Recovery Assessment Scale. 
Evidence of construct validity was provided by a pattern of correlations between 
scores on each of the five subscales. That is, there were positive correlations between 
adjacent stages (i.e. Stages 4 and 5), and negative correlations between distant stages 
(Stages 1 and 5). This provided some initial evidence for the sequential nature of the 
stages of recovery. However, a cluster analysis found 3 stage-based clusters rather 
than the expected five. The authors concluded that the STORI was not sensitive 
enough to yield five stages rather than that recovery is better conceptualised in three 
stages. The skew in distribution towards later stages of recovery for their sample 
could account for the inability to identify distinct clusters for earlier stages.  
This study aimed to evaluate the STORI with a UK sample.  
 
 
Methods 
 
Sample 
 
The study was conducted with three specialist mental health teams in 
Croydon, South London: a Rehabilitation and Recovery Team; an early intervention 
in psychosis team; and an inpatient recovery unit. These teams were chosen to span 
the spectrum of people using specialist mental health services, with a full range in the 
expected contact time with mental health services and levels of complexity of need. 
The intention was to ensure a wider spread than was available in the self-selecting 
participant pool from the research database used in the Australian study.  
The London Borough of Croydon is a suitable setting for a UK validation 
study because of the mix in ethnic background and levels of deprivation. The 2001 
Office of National Statistics data recorded a population of 330, 587, 63.7% of whom 
were British, 7.9% Caribbean, 6.5% Irish / other white, 6.4% Indian, 4.4% African 
and 2.3% Pakistani. Its average Mental Illness Needs Index (MINI: Glover, Robin, 
Emami & Arabscheibani, 1998) is 100.1, with a range from 81.7 (most affluent 
electoral ward) to 111.1 (most deprived electoral ward). This indicates that social 
deprivation levels vary widely within an overall area with average levels for England. 
This makes the borough a highly nationally representative location. Demographic data 
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were not given in the Australian validation study. However, it was considered likely 
that the sample would be culturally different to the sample studied by Andresen and 
colleagues (2006).  
 
Measures 
 
The STORI is a 50-item self-report questionnaire (Andresen et al, 2006). Ten themes 
are assessed, each with five items (each ranging from 0 ‘Not at all true now’ to 5 
‘Completely true now’) mapping onto the five proposed stages of recovery. This 
produces a score for each stage ranging from 0 to 50, and the respondent is allocated 
to the stage with the highest score. If two stages are tied, then the participant is 
allocated to the higher stage. 
The Feedback Questionnaire was designed for this study to assess face validity 
and feasibility from the perspective of participants completing the STORI. It contains 
seven statements (each using a five-point Likert scale) assessing feasibility criteria 
proposed by Slade and colleagues (1999). Respondents rate agreement with the 
statements using a five point Likert scale from Strongly agree to Strongly disagree. 
They then comment on positive and negative aspects of the STORI, including 
comprehensibility of items. 
The Recovery Assessment Scale (RAS) is a 50-item self-report questionnaire 
comprising 50 statements rated on a five-point Likert scale from 1 to 5 (Corrigan et al, 
1999). The resulting single recovery score ranges from 50 (lowest recovery) to 250. 
The RAS has published psychometric properties and has been subject to large scale 
factor analysis (Corrigan et al, 2004). It has adequate test-retest reliability and internal 
consistency. Positive correlations with recovery-related measures of hope, 
empowerment and quality of life provide evidence of concurrent validity, along with 
negative correlations with measures of psychiatric symptoms. 
 
Procedure  
 
After giving consent to take part in the study, participants completed the STORI, the 
feedback questionnaire, and the RAS. At this point, they were able to end their 
participation or to continue and complete the STORI again, for the purpose of test-
retest reliability analysis. If they gave consent to do this, they were given a distracter 
task for four minutes. The task was the ‘digit symbol coding’ sub-test from the WAIS, 
which involved drawing symbols using a key. It was chosen because performing the 
task requires good concentration, preventing participants from engaging in any 
rehearsal of their answers. Following the distracter task, they completed the STORI 
for a second time.  
 
Data analysis 
 
Data were normally distributed, and parametric analyses were used where appropriate.  
 Concurrent validity was evaluated using Pearson correlations between STORI 
stage scores and the RAS total score.  
Construct validity was investigated in two ways. First, Pearson correlations 
were conducted between scores in each stage. The stage model of recovery postulates 
that the five stages are sequential. The ratings of people allocated to stage 1 should be 
closer to the ratings of people in stage 2 than to people in other stages. Similarly, 
people in stage 5 should rate closer to those in stage 4 than with people allocated to 
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other stages. In order to demonstrate this, a particular pattern of correlations was 
expected. Positive correlations were expected between adjacent stages and weak or 
negative correlations between more distant stages. Second, a hierarchical cluster 
analysis using Ward’s method investigated whether STORI items cluster into groups 
mapping on to the five stages of recovery. The cluster analysis was run to identify 
two, three, four and five cluster solutions and the dendrograms were examined to 
identify the best solution. Cluster analysis was considered an appropriate means of 
identifying the extent to which participants completing the STORI fell into groups 
mapping onto the five stages of recovery proposed by Andresen and colleagues. 
Test-retest reliability was investigated using intra-class Pearson correlations to 
assess the association between participants’ STORI stage scores over two 
administrations.  
Internal consistency was investigated by computing Cronbach’s alpha scores 
for each of the five stages. Data were analysed using SPSS Version 15. 
An a priori power analysis was used to inform the appropriate sample size. 
Correlation between the STORI and the RAS (power = 0.8; effect size = 0.7; α = .05) 
required a sample size of 43. For the cluster analysis there must be as many sets of 
data as questions in the questionnaire, so 50 participants were necessary. 
 
 
Ethics 
 
Ethical approval was obtained from the Bromley NHS Research Ethics Committee 
and the University of Surrey Research Ethics Committee. Research and Development 
approval was granted by the South London and Maudsley NHS Foundation Trust. 
 
Results 
 
Descriptive data  
 
A total of 52 people participated in the study. Nobody that received information on 
the study refused to participate. Two participants started completing the 
questionnaires but were unable to finish. The majority (66% of participants) were 
male and their ages ranged between 18 and 60 years. Thirty eight of the participants 
were referrals from community teams and 12 were inpatients. (the rehabilitation unit) 
the listing of referrals needs to match the referring teams listed under ‘sample’. 
Diagnostic information was gathered from participants’ computerised clinical files 
(for which consent was obtained). There was a range of diagnoses, most of which 
included psychosis (i.e. schizophrenia, psychotic disorders). Information related to 
professional descriptions of current symptoms or severity was not collected since the 
STORI is designed to measure recovery from a consumer perspective. Participants 
were varied in ethnic backgrounds. Just under half of the sample were white British 
and the remainder reflected the diversity of the overall population being studied. 
Detailed demographic and clinical characteristics of the sample can be found in Table 
1. 
 
Insert Table 1 here 
 
STORI stage scores and allocations are listed in Table 2. The mean scores for 
the stages suggest that items within the stage of Moratorium received a lower level of 
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endorsement and were less relevant to the participants. Consistent with the findings of 
Andreson et al (2006), the majority of participants were allocated to the later stages of 
recovery (rebuilding and growth). However, a more balanced profile of allocations 
was evident across the sample within the current study as a significant minority of 
participants were allocated to earlier stages of recovery (awareness and preparation).  
 
Insert Table 2 here 
 
 
Concurrent validity 
 The mean score on the RAS was 156.8 out of 205 (range = 121 – 199; sd = 
21.9). Correlations between the five STORI stages and RAS total score are shown in 
Table 3. The significant negative correlation between the STORI stage 1 and RAS 
total score is evidence that people who identify strongly with the early stage of 
recovery are also likely to be ‘less recovered’ on the RAS. Conversely, those people 
who identified with stages 3, 4 and 5 are likely to be ‘more recovered’ according to 
the RAS. The pattern of correlations suggests that the stages are sequential in nature. 
 
Insert Table 3 here 
 
Construct validity 
The results of the Pearson correlations conducted between scores for each of 
the five stages are presented in Table 4. The pattern of correlations shows that people 
identifying strongly with stage 1 items are unlikely to endorse items in the other 
stages (and are least likely to endorse stage 5 items). In contrast, those people 
identifying strongly with items in stage 3 and 4 are likely also to identify with stage 5 
items.  
 
Insert Table 4 here 
 
 Visual inspection of the dendrograms resulting from the cluster analysis 
indicated that a three-cluster model was the best fit with the data. The dendrograms, 
as generated by SPSS, can be seen in figure 1 and cluster memberships are 
summarised in Table 5. Cluster 1 consisted of seven items, all of which were from 
stage 1; cluster 2 contained 23 items: three from stage 1, nine from stage 2, eight from 
stage 3 and three from stage 4. Cluster 3 contained 20 items: one from stage 2, two 
from stage 3, seven from stage 4 and all ten items from stage 5. To investigate 
concurrent validity of these three stages, cluster scores were computed for each 
participant. Because the clusters had uneven numbers of items, the mean score for 
items within each cluster was used.  Pearson correlations were then conducted 
between the clusters and the RAS. This showed the expected pattern of correlations. 
That is, there was a significant negative correlation between Cluster 1 and the RAS (-
.643; p<.001), a moderate and significant positive correlation between Cluster 2 and 
the RAS (.323; p<.005) and a strong and significant positive correlation between 
Cluster 3 and the RAS (.745; p<.001).  
 
Insert Figure 1 here 
Insert Table 5 here 
 
 
 8 
 
 
Stability 
Cronbach’s Alpha was calculated for each of the five stage subscales. Alpha 
values for the five stages were between 0.81 and 0.87. These are all above 0.8, 
indicating adequate internal consistency (Kline, 2000). 
 Test-retest reliability was assessed using data from 22 participants who 
completed the STORI for a second time after completing a four minute distracter task. 
The remainder of the 50 participants declined to complete the STORI for a second 
time. Pearson correlations between participants’ stage scores were 0.96 for stage 1 
(p<.001 level); 0.9 for stage 2 (p<.001); 0.91 for stage 3 (p<.001); 0.92 for stage 4 
(p<.001) and .95 for stage 5 (p<.001). 
  
Face validity and feasibility  
 The Feasibility Questionnaire was completed by 49 participants, the results of 
which are shown in Table 6. The table shows the breakdown of responses to questions 
addressing each of the themes addressed by the feasibility questionnaire. 
 
Insert table 6 here 
 
Discussion 
This study offers evidence to suggest that the STORI is a valid and reliable 
measure when used in the UK. Correlations between the STORI stages and the RAS 
total score are evidence of the concurrent validity of the STORI, and feedback from 
participants provided evidence for the face validity and feasibility of the STORI. 
Correlations between stage scores within the STORI provided initial evidence for the 
construct validity of the STORI as a measure of the five stage model of recovery. 
However, the cluster analysis found only three clusters. STORI stage scores showed 
acceptable test-retest reliability and internal consistency.    
 This study provided evidence for psychometric properties that were not 
assessed by Andresen et al (2006). Using the Feedback Questionnaire, there was 
evidence of face validity and feasibility of the STORI as a measure of recovery from 
the perspective of service users. Feasibility was investigated using five criteria 
proposed by Slade and colleagues (1999). Brevity was adequate: the large majority of 
the participants thought that the STORI was an acceptable length at about 11 minutes. 
The measure was simple to use, with 84% of participants stating the STORI were easy 
to understand. Relevance was shown by the majority (75%) of participants agreeing 
that the questions in the STORI are important for thinking about recovery.  Only 5% 
of participants felt that there were questions in the STORI that they did not wish to 
answer. Therefore it is concluded that they found it acceptable. A majority of the 
participants thought that completing the STORI had helped them think about their 
recovery, providing  inconclusive evidence of the personal value of the measure. 
However, it is notable that 80% thought that the STORI could be used by staff to 
think about how they help service users. 
 There was initial evidence for the test-retest reliability of the STORI stages. 
This was, however, limited by the use of an in-session distracter task that is unlikely 
to have eliminated practice effects. 
 Consistent with the initial validation study (Andresen et al, 2006), the pattern 
of correlations with the RAS provided evidence of concurrent validity of the STORI. 
There were strong positive correlations between stage 4 and 5 scores and the RAS 
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total score, and significant negative correlations between the RAS and stage 1. The 
correlation between stage 2 and the RAS was positive but weak and non-significant. 
There was a moderate correlation between stage 3 and the RAS. This pattern of 
negative to positive correlations through the five stages can be taken as indication of 
the concurrent validity of the later stages of STORI as measures of recovery. 
However, there was a very small difference in the magnitude of the stage 4 and 5 
correlations with the RAS. Furthermore, there was a significant positive correlation 
between stage 3 scores and the RAS. In the original validation (Andresen et al, 2006), 
there was no correlation between stage 3, and a weak correlation between stage 4, and 
the RAS. This would lead to the question of whether these items capture distinctly 
different stages of recovery, or are tapping into the same processes as the stage 5 
items.  
The three stage model derived from the cluster analysis compliments the 
pattern identified by Andresen and colleagues (2006). The pattern within the three 
clusters was also similar: cluster 1 in that study contained all 10 stage 1 items; the 
second cluster contained 24 items: all of stages 2 and 3 plus 4 from stage 4; and the 
third cluster contained 16 items: the remaining six from stage 4 and all of stage 5. 
This study, therefore, has provided evidence that, whilst the correlations between the 
five stages in the STORI and the RAS show the expected sequential pattern, they do 
not form distinct clusters that reflect a robust measure of the five stage model.  
The question remains, however, whether the five stage model of recovery is a 
valid one (and the STORI is not a valid measure of it) or whether recovery is better 
described in terms of three stages. There is evidence of three stage models in the 
recovery literature (Baxter & Diehel, 1998; Young & Ensing, 1999; Spaniol et al, 
2002), and these informed the analysis through which the five stage model of 
recovery was developed. Similar to Andresen and colleagues (2006) it is concluded 
that further development is necessary in order for the STORI to distinguish between 
five stages of recovery. However, at present, a consideration of the evidence from 
both the UK and Australia arguably leads to the conclusion that three stages of 
recovery can be identified using measures and, therefore, that a three-stage model 
could form the basis of further research into stages of recovery. The clinical 
implications of a validated stage model of recovery are that interventions can be 
tailored to the individual. Just as motivational interviewing is a more helpful approach 
than a detoxification programme for substance abusers who are pre-contemplative of 
change, it may be that (for example) raising expectations about taking responsibility 
for one’s life is toxic for people in the Moratorium stage and beneficial in the 
Awareness stage. 
 Efforts to measure recovery also raise conceptual issues. Evidence-based 
medicine is primarily modernist. In relation to measurement, it emphasises reliability 
to reduce measurement error and validity to ensure the intended underlying construct 
is what is measured. This contrasts with the recovery approach, which is somewhat 
aligned with a post-modern perspective in its emphasis on personal values and 
subjective perspectives, plural truths and individualised personal outcomes. These 
tensions are being addressed more explicitly in the academic literature, (Fisher & 
Happell, 2009), and well-developed proposals for reconciling this apparent 
contradiction are being put forward (Silverstein & Bellack, 2009). For example, the 
use of an invariant primary outcome for all participants in a clinical trial does not 
capture the individual nature of recovery, and innovative approaches to 
individualising clinical end-point measurement are now being evaluated in the 
REFOCUS Study (www.iop.kcl.ac.uk/departments/?locator=1073). 
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A strength of this study is that it is a demonstration that it is possible to 
measure recovery concepts in UK clinical services. In an era of evidence-based 
practice (Holloway, 2002) it has been argued that being able to measure recovery 
concepts is essential in order for the concepts to have a lasting effect upon the 
delivery of services (Slade & Hayward, 2007; Schrank & Slade, 2007). However, the 
idea that recovery should be measured has been criticised by authors who argue that 
focussing on outcomes does not fit with concepts of recovery as a process and 
therefore represents an unwelcome development (e.g. Bonney & Stickley, 2008). 
 There are some limitations to the present study, one of which is the skewed 
spread of stage allocations. Similar to the original validation study, the latter stages of 
recovery were more populated than stages 1 and 2. There are a number of 
explanations for this. First, it is possible that the skew in allocations was a reflection 
of the study population, i.e. that most people were in the advanced stage of recovery. 
It is notable that most of the participants came through the community teams – further 
research might look into the spread of stage allocations in consumers who are 
inpatients or very recently discharged from hospital. Second, the participants may 
have identified the socially desirable answers (i.e. those that reflect the latter stages of 
recovery) and responded accordingly. Third, the skew may reflect a feature of the 
STORI itself. For example, that the questions designed to reflect stages 2 and 3 are 
worded very similarly and therefore participants respond similarly to both and are 
allocated the later stage. These concerns can be addressed by re-wording STORI 
items that loaded onto the same clusters in the cluster analysis and conducting a new 
validation study. Fourth, the study would have benefited from a larger sample size. In 
particular, this would have allowed for a more robust cluster analysis. However, time 
limitations prevented the recruitment of more participants. 
Taking the above findings into account, the STORI cannot be used in its 
present form to allocate individuals to stages of recovery. The failure of both the 
original validation and this study to find five stage-based clusters could be seen as 
evidence that the five stage model is not a valid conceptualisation of recovery. This is 
a new area of research, with several stage models proposed (e.g. National Institute for 
Mental Health in England, 2004), some of which emphasise that recovery processes 
are non-linear. It has been proposed that the metaphor of a spiral may be more helpful 
than linear stages, as often individuals re-visit earlier stages before progressing on to 
later stages (Slade, 2009). This complexity is addressed in other measures, such as the 
Recovery Outcomes Star (National Institute for Mental Health in England, 2008). 
Future research should focus on the development and psychometric analysis of a 
shorter version based on a three-stage model of recovery.  
Despite the shortcomings of the STORI, it remains a promising measure of the 
user-defined recovery concept. Developing and using recovery measures in routine 
clinical services is an important component of the transformation from an evidence-
based treatment system to an evidence-based recovery system. Measures such as 
STORI have at least four potential clinical uses (Slade, 2009). First, identifying the 
current stage of recovery can inform clinical decision-making about the most 
appropriate intervention. Second, aggregated data can provide a more recovery-
sensitive measure of casemix. This can be used for work-force planning, to better 
match the skill-mix in a team with the needs of people on the team caseload. Third, 
using an explicitly recovery-oriented measure such as STORI is one approach to 
shifting the culture of care: talking about recovery is in itself an intervention. Finally, 
stage 5 scores could be tracked over time as recovery-focussed outcome data. Overall, 
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given the positive feedback from participants, the measure could be used as a means 
of promoting recovery ideas in clinical services.  
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Table 1 Demographic and clinical information 
Characteristic N  
Age, mean (standard deviation) 32.4 (12.1) 
Men, n (%) 33 (66) 
Ethnicity, n (%) 
White 
British 24 (48) 
Non-British 5 (10) 
Black 
African 7 (14) 
Caribbean 7 (14) 
Other 1 (2) 
Asian 3 (6) 
Other 3 (6) 
Immigration status   
British 38 (76) 
Permanent UK resident 9 (18) 
Seeking asylum 3 (6) 
Highest Educational Level, n (%) 
Degree or equivalent professional qualification 1 (2) 
School leaving exams or subsequent equivalent 
(e.g. National Vocational Qualification) 
35 (70) 
Basic literacy skills 13 (26) 
Unknown 1 (2) 
Living arrangements, n (%) 
Living alone 10 (20) 
Living with other adults 22 (44) 
Living with family 16 (32) 
Living with partner 2 (4) 
Housing Status  
Independent permanent accommodation 24 (48) 
Temporary accommodation 2 (4) 
24-hour supported accommodation 18 (36) 
Other supported accommodation  6 (12) 
Employment Status, n (%) 
Open market employment 5 (10) 
Sheltered employment 4 (8) 
Not employed (student) 6 (12) 
Primary Diagnosis, n (%) 
Schizophrenia 21 (42) 
Other psychotic disorders 11 (22) 
Mental / behavioural disorder due to 
alcohol / drugs 
6 (12) 
Bipolar affective disorder 5 (10) 
Depression 3 (6) 
Obsessional disorders 2 (4) 
Schizoaffective disorder 1 (2) 
Emotionally unstable personality disorder 1 (2) 
Service, n (%) 
Early Intervention service 19 (38%) 
 15 
Rehabilitation and Recovery Team 19 (38%) 
Rehabilitation unit 12 (24%) 
Length of Contact, n (%) 
First year of contact 8 (16%) 
Between 1 and 2 years contact 4 (8%) 
Between 2 and 5 years contact 20 (40%) 
More than 5 years contact 18 (36%) 
Not employed (due to illness) 35 (70) 
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Table 2 Stage allocations for the STORI (n=50) 
 
 Current study (N=50) Andresen et al (2006) 
(N=94) 
Stage scores, mean (st dev) 
1 – Moratorium 19.9 (10.2)  
2 – Awareness 28.4 (11.3) 
3 – Preparation  28.5 (10.4) 
4 – Rebuilding  32.4 (10.3) 
5 – Growth  31.4 (11.1) 
Stage allocation, n (%) 
1  4 (8) 8 (9) 
2 11 (22) 2 (2) 
3 5 (10) 5(5) 
4 14 (28) 30 (32) 
5 16 (32) 48 (51) 
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Table 3 Correlations between STORI stage scores and RAS total score 
 
Stage, correlation with RAS 
(significance); n = 50 
1 -.640 (p<.001) 
2 .138 (p = .340, ns) 
3 .458 (p<.001) 
4 .671 (p<.001) 
5 .735 (p<.001) 
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Table 4 – correlations between stages of the STORI 
 
 Stage 2 Stage 3 4 5 
Stage 1 .183  
(p = .205, ns) 
-.154 
(p=.285, ns) 
-.429  
(p <.005) 
-.479 
(p<.001) 
2  .794 
(p<.001) 
.518 
(p<.001) 
.341 
(p<.001) 
3   .844 
(p<.001) 
.705 
(p<.001) 
4    .863 
(p<.001) 
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Table 5 Summary of cluster analyses 
 
2 Clusters 1 2  
Cluster 
Membership 
(stage) 
1,11,16,21,31
,36,41,46 
(stage 1 
items) 
2 (stage 2 
item) 
6,26 (stage 1 
items) 
7,12,17,22,27,
32,37,42,47 
(stage 2 items) 
3,8,13,18,23,2
8,33,38,43,48 
(stage 3 items) 
4,9,14,10,19,2
4,29,34,39,44,
49 (stage 4 
items) 
5,10,15,20,25,
30,35,40,45,50 
(stage 5 items) 
 
3 Clusters 1 2 3  
Cluster 
Membership 
(stage) 
1,11,16,21,31
,36,46 (all 
stage 1) 
6,26,41 (all 
stage 1) 
2,7,12,17,22,2
7,37,42,47 (all 
stage 2) 
3,8,23,28,33,3
8,43,48 (all 
stage 3) 
14,19,24 (all 
stage 4) 
32 (stage 2) 
13,18 (stage 3) 
4,9,29,34,39,4
4,49 (stage 4) 
5,10,15,20,25,
30,35,40,45,50 
(stage 5) 
 
 
4 Clusters 1 2 3 4  
Cluster 
Membership 
(Stage) 
1,11,16,21,31
,36,46 (stage 
1 items) 
41 (stage 1 
item) 
2,7,12,17,22,2
7,32,37,42,47 
(stage 2 items) 
3,8,23,28,33,4
3,48 (stage 3 
items) 
14,19,24 
(stage 4 items) 
13,18,38 
(stage 3 items) 
4,9,29,34,39,4
4,49 (stage 4 
items) 
5,10,15,20,25,
30,35,40,45,50 
(stage 5 items) 
6,26 (stage 1 
items) 
 
 
 
5 Clusters 1 2 3 4 5 
Cluster 
Membership 
(stage) 
1,11,16,21,31
,36,46 (stage 
1 items) 
41 (stage 1 
item) 
2,12,27,42,47 
(stage 2 items) 
3,28,33,43 
(stage 3 items) 
19,24 (stage 4 
items) 
13,18 (stage 3 
items) 
4,9,29,34,39,4
4,49(stage 4 
items) 
5,10,15,20,25,
30,35,40,45,50 
(stage 5 items) 
6,26 (stage 1 
items) 
7,17,22,32,37 
(stage 2 items) 
8,23,38,48 
(stage 3 items) 
14 (stage 4 
item) 
 20 
Table 6 Feasibility of STORI (n=49) 
 
n (%) 
 
Strongly 
disagree 
Disagree Not sure Agree Strongly 
agree 
1. Easy to understand 
 
1 (2) 2 (4) 5 (10.2) 29 (59.2) 12 (24.5) 
2. Helped me to think 
about my recovery 
0 (0) 7 (14.3) 15 (30.6) 19 (38.8) 8 (16.3) 
3. Items are important for 
thinking about  recovery 
0 (0) 2 (4.1) 11 (22.4) 27 (55.5) 9 (18.4) 
4. Too long 
 
5 (10.2) 34 (69.4) 6 (12.2) 4 (8.2) 0 (0) 
5. Questions I did not wish 
to answer 
10 (20.4) 30 (61.2) 7 (14.3) 2 (4.1) 0 (0) 
6. Prepared to fill in at 
different times 
0 (0) 5 (10.2) 8 (16.3) 25 (51.0) 11 (22.4) 
7. Helpful for staff 
 
1 (2.0) 0 (0) 9 (18.4) 27 (55.1) 12 (24.5) 
Completion time, mean 
(minutes) (s.d.) 
11.4 (4.86) 
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Figure 1 Dendrogram – 3 cluster 
 
 
CASE   0         5        10        15        20        25 
STORI  +---------+---------+---------+---------+---------+ 
Item 
  44   -+ 
  45   -+-+ 
  50   -+ | 
  20   -+ +-+ 
  40   -+-+ | 
  15   -+ | +-+ 
  29   ---+ | | 
  32   -+-+ | | 
  49   -+ +-+ | 
   8   -+-+   | 
  10   -+     | 
   4   -+-+   | 
  39   -+ +---+ 
  18   -+ |   +---------+ 
  35   -+-+   |         | 
  25   -+     |         | 
  34   -+     |         | 
   5   ---+-+ |         | 
  30   ---+ +-+         +-------------------------------+ 
  13   -----+           |                               | 
   6   ---+-------+     |                               | 
  26   ---+       |     |                               | 
   9   -+-+       |     |                               | 
  14   -+ |       |     |                               | 
   7   -+-+-----+ +-----+                               | 
  22   -+ |     | |                                     | 
  23   -+-+     | |                                     | 
  48   -+ |     | |                                     | 
  37   -+-+     | |                                     | 
  38   -+ |     +-+                                     | 
  17   ---+     |                                       | 
   2   ---+---+ |                                       | 
  41   ---+   | |                                       | 
  12   -+-+   | |                                       | 
  43   -+ |   +-+                                       | 
  19   -+ +-+ |                                         | 
  24   -+-+ | |                                         | 
   3   -+ | | |                                         | 
  27   -+-+ +-+                                         | 
  28   -+   |                                           | 
  33   ---+ |                                           | 
  42   ---+-+                                           | 
  47   ---+                                             | 
  16   -+-+                                             | 
  46   -+ +-+                                           | 
  11   -+ | |                                           | 
  31   -+-+ +-------------------------------------------+ 
   1   -+   | 
  21   ---+-+ 
  36   ---+ 
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